- Correction
- Open access
- Published:
Correction to: Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers*
BMC Pharmacology and Toxicology volume 22, Article number: 37 (2021)
The Original Article was published on 11 January 2019
Correction to: BMC Pharmacol Toxicol 20, 5 (2019)
https://doi.org/10.1186/s40360-018-0280-8
After publication of the original article [1], an error was identified in the Results section, with regard to values of Table 1.
The incorrect sentence is:
SIB peak plasma concentrations were 207.1 mg/L for SPC and 12.6 mg/L for SM tablets. All pharmacokinetic parameters differed significantly between formulations (P < 0.0001).
The correct sentence is:
SIB peak plasma concentrations were 207.1 ng/L for SPC and 12.6 ng/L for SM tablets. All pharmacokinetic parameters differed significantly between formulations (P < 0.0001).
The original article has been corrected.
Reference
Méndez-Sánchez N, et al. Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers*. BMC Pharmacol Toxicol. 2019;20:5. https://doi.org/10.1186/s40360-018-0280-8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Méndez-Sánchez, N., Dibildox-Martinez, M., Sosa-Noguera, J. et al. Correction to: Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers*. BMC Pharmacol Toxicol 22, 37 (2021). https://doi.org/10.1186/s40360-021-00500-2
Published:
DOI: https://doi.org/10.1186/s40360-021-00500-2